Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
158800
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of Series 25 Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment
発行・処分する株式数158,800Shares
Number of shares delivered during the relevant month: 158,800 shares (new shares)
発行済株式総数
Exercise ratio subject to exercise restrictions: 0.45% (158,800 shares delivered across all series / 34,666,419 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise price during the relevant month: ¥194.97–¥243.47. Floor under the adjustment clause: Not disclosed
Number of Stock Acquisition Rights
Total number issued: 86,000; unexercised at the end of the month preceding the relevant month: 41,060; unexercised at the end of the relevant month: 39,472
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Timing 8 December 2025 / Type Issuance of the 25th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Series 25 Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment |
| Number of shares to be issued or disposed of | Number of shares delivered during the relevant month: 158,800 shares (new shares) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 0.45% (158,800 shares delivered across all series / 34,666,419 listed shares outstanding as of the payment date for the issuance) |
| Exercise price | Exercise price during the relevant month: ¥194.97–¥243.47. Floor under the adjustment clause: Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 86,000; unexercised at the end of the month preceding the relevant month: 41,060; unexercised at the end of the relevant month: 39,472 |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 8 December 2025 / Type Issuance of the 25th Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyTotal number of issued sharesBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the Series 25 Stock Acquisition Rights in June 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.